NCT00243893View on ClinicalTrials.gov

Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
AneurysmsArteriovenous Malformations
Interventions
DRUG

minocycline

Take minocycline 50mg BID x2 years. Labs drawn at baseline, then every-6 months. MRI is done at baseline and completion of study.

DRUG

doxycycline

Take doxycycline 50mg BID x2 years. Labs drawn at baseline, then every-6 months. MRI is done at baseline and completion of study.

Trial Locations (1)

94143

University of California, San Francisco

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of California, San Francisco

OTHER

NCT00243893 - Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms | Biotech Hunter | Biotech Hunter